Chrystal M. Paulos, Ph.D.
Affiliations: | 2004 | Purdue University, West Lafayette, IN, United States |
Area:
ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseasesGoogle:
"Chrystal Paulos"Mean distance: 12.9 | S | N | B | C | P |
Parents
Sign in to add mentorPhilip S. Low | grad student | 2004 | Purdue | |
(From optimal dosing of folate-conjugates for the diagnosis and treatment of cancer to novel therapies in arthritis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Horvat NK, Karpovsky I, Phillips M, et al. (2024) Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy. Journal For Immunotherapy of Cancer. 12 |
Rangel Rivera GO, Dwyer CJ, Knochelmann HM, et al. (2023) Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and anti-tumor immunity. Cancer Research |
Bennion KB, Tariq M, Wyatt MM, et al. (2023) FcγRIIB expressed on CD8 T cells limits responsiveness to PD-1 checkpoint inhibition in cancer. Science Translational Medicine. 15: eadd1868 |
Zhang H, Passang T, Ravindranathan S, et al. (2023) The magic of small-molecule drugs during expansion in adoptive cell therapy. Frontiers in Immunology. 14: 1154566 |
Wyatt MM, Huff LW, Nelson MH, et al. (2023) Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cell therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Rangel Rivera GO, Dwyer CJ, Knochelmann HM, et al. (2023) The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner. Biorxiv : the Preprint Server For Biology |
Ware MB, Phillips M, McQuinn C, et al. (2023) Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell and CXCR3-dependent manner. Jci Insight |
Camargo CP, Muhuri AK, Alapan Y, et al. (2023) A dhesion analysis via a tumor vasculature-like microfluidic device identifies CD8 T cells with enhanced tumor homing to improve cell therapy. Cell Reports. 42: 112175 |
Riesenberg BP, Hunt EG, Tennant MD, et al. (2022) Stress-mediated attenuation of translation undermines T-cell activity in cancer. Cancer Research |
Smith AS, Knochelmann HM, Wyatt MM, et al. (2022) B cells imprint adoptively transferred CD8 T cells with enhanced tumor immunity. Journal For Immunotherapy of Cancer. 10 |